Trial intelligence / Profile preview

Manuka Honey for Esophagitis Pain in Lung Cancer

NCT01262560Phase 2Completed

Sponsor
NRG Oncology
Start
Feb 2012
Primary completion
Feb 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, open-label trial of manuka honey in radiation-induced esophagitis (3 arms), sponsored by NRG Oncology. Primary endpoint: Numerical Rating Pain Scale for Pain on Swallowing at 4 weeks. Started Feb 2012; status: completed.

02

Drugs

manuka honey
03

Conditions

radiation-induced esophagitis

Beyond the preview

Go deeper on NCT01262560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01262560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call